This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Source: Deloitte Combining these types of health data allows pharmaceuticalcompanies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?
As any new particular drug should be approved before becoming a consumable product, pharmaceuticalcompanies must conduct research and drug trials during drug discovery. A specifically tuned neural network can keep data secure and manage electronic medicalrecords (EMR) to store patients’ sensitive information and treatment records.
Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. PharmaceuticalcompaniesPharmaceuticalcompanies can transform their approaches to clinical trials with the help of 5G networks.
The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is estimated that this will reach 70% by 2035. Industry interest. Breakthroughs to come.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content